BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 12667176)

  • 41. Effectiveness of clozapine and olanzapine: a comparison in severe, psychotically ill patients.
    Di Lorenzo R; Tondelli G; Genedani S
    Int J Neuropsychopharmacol; 2001 Jun; 4(2):135-7. PubMed ID: 11466163
    [No Abstract]   [Full Text] [Related]  

  • 42. Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study.
    Stein MB; Kline NA; Matloff JL
    Am J Psychiatry; 2002 Oct; 159(10):1777-9. PubMed ID: 12359687
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Long-term therapy with intuition].
    MMW Fortschr Med; 2003 May; 145 Suppl 2():87. PubMed ID: 14579492
    [No Abstract]   [Full Text] [Related]  

  • 44. Torsade de pointes during combined treatment with risperidone and citalopram.
    Blaschke D; Parwani AS; Huemer M; Rolf S; Boldt LH; Dietz R; Haverkamp W
    Pharmacopsychiatry; 2007 Nov; 40(6):294-5. PubMed ID: 18030657
    [No Abstract]   [Full Text] [Related]  

  • 45. Serotonin syndrome: a complex but easily avoidable condition.
    Dvir Y; Smallwood P
    Gen Hosp Psychiatry; 2008; 30(3):284-7. PubMed ID: 18433663
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Olanzapine, risperidone and haloperidol in the treatment of adolescent patients with schizophrenia.
    Gothelf D; Apter A; Reidman J; Brand-Gothelf A; Bloch Y; Gal G; Kikinzon L; Tyano S; Weizman R; Ratzoni G
    J Neural Transm (Vienna); 2003 May; 110(5):545-60. PubMed ID: 12721815
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hypothermia induced by risperidone and olanzapine in a patient with Prader-Willi syndrome.
    Phan TG; Yu RY; Hersch MI
    Med J Aust; 1998 Aug; 169(4):230-1. PubMed ID: 9734590
    [No Abstract]   [Full Text] [Related]  

  • 48. The effectiveness of olanzapine in treatment-refractory schizophrenia when patients are nonresponsive to or unable to tolerate clozapine.
    Dossenbach MRK ; Beuzen JN; Avnon M; Belmaker RH; Elizur A; Mark M; Munitz H; Schneidman M; Shoshani D; Kratky P; Grundy SL; Tollefson GD
    Clin Ther; 2000 Sep; 22(9):1021-34. PubMed ID: 11048902
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Fast control of manic or mixed episodes. Atypical neuroleptics for bipolar patients].
    MMW Fortschr Med; 2003 May; 145 Suppl 2():86-7. PubMed ID: 14579491
    [No Abstract]   [Full Text] [Related]  

  • 50. More cases of paroxetine withdrawal syndrome.
    Pacheco L; Malo P; Aragues E; Etxebeste M
    Br J Psychiatry; 1996 Sep; 169(3):384. PubMed ID: 8879736
    [No Abstract]   [Full Text] [Related]  

  • 51. Olanzapine-associated type 2 diabetes mellitus.
    Opp D; Hildebrandt C
    Schizophr Res; 2002 Jul; 56(1-2):195-6. PubMed ID: 12084434
    [No Abstract]   [Full Text] [Related]  

  • 52. Neuroleptic malignant syndrome after addition of haloperidol to atypical antipsychotic.
    Mujica R; Weiden P
    Am J Psychiatry; 2001 Apr; 158(4):650-1. PubMed ID: 11282706
    [No Abstract]   [Full Text] [Related]  

  • 53. Case report of withdrawal syndrome after olanzapine discontinuation.
    Nayudu SK; Scheftner WA
    J Clin Psychopharmacol; 2000 Aug; 20(4):489-90. PubMed ID: 10917413
    [No Abstract]   [Full Text] [Related]  

  • 54. Olanzapine in the treatment of apathy in previously depressed participants maintained with selective serotonin reuptake inhibitors: an open-label, flexible-dose study.
    Marangell LB; Johnson CR; Kertz B; Zboyan HA; Martinez JM
    J Clin Psychiatry; 2002 May; 63(5):391-5. PubMed ID: 12019662
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mania in a case of polypsychopharmacology: pharmacodynamic and pharmacokinetic considerations. Do you believe in magic?
    Preskorn SH
    J Psychiatr Pract; 2007 May; 13(3):178-83. PubMed ID: 17522561
    [No Abstract]   [Full Text] [Related]  

  • 56. Recognition and treatment of serotonin syndrome.
    Frank C
    Can Fam Physician; 2008 Jul; 54(7):988-92. PubMed ID: 18625822
    [No Abstract]   [Full Text] [Related]  

  • 57. [Neuroleptic malignant syndrome in a patient treated with olanzapine].
    Horni G; Meirik K; Lund MB
    Tidsskr Nor Laegeforen; 2003 Oct; 123(20):2867-9. PubMed ID: 14600711
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Olanzapine-induced neuroleptic malignant syndrome.
    Burkhard PR; Vingerhoets FJ; Alberque C; Landis T
    Arch Gen Psychiatry; 1999 Jan; 56(1):101-2. PubMed ID: 9892264
    [No Abstract]   [Full Text] [Related]  

  • 59. Low blood glucose and olanzapine.
    Budman CL; Gayer AI
    Am J Psychiatry; 2001 Mar; 158(3):500-1. PubMed ID: 11230004
    [No Abstract]   [Full Text] [Related]  

  • 60. Benefits of olanzapine as first-line schizophrenia therapy.
    Cohen LJ
    Am J Health Syst Pharm; 1999 Aug; 56(15):1559-60, 1563-4. PubMed ID: 10478999
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.